Alnylam Pharmaceuticals (ALNY) Gross Margin (QoQ) (2018 - 2026)

Alnylam Pharmaceuticals (ALNY) Gross Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Alnylam Pharmaceuticals 37.04 Bn 34.03 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 662.00
Dec 31, 2025 -861.00
Sep 30, 2025 257.00
Jun 30, 2025 21,559.00
Mar 31, 2025 -21,664.00
Dec 31, 2024 -94.00
Sep 30, 2024 -617.00
Jun 30, 2024 85.00
Mar 31, 2024 532.00
Dec 31, 2023 -578.00
Sep 30, 2023 1,305.00
Jun 30, 2023 -1,066.00
Mar 31, 2023 80.00
Dec 31, 2022 3.00
Sep 30, 2022 133.00
Jun 30, 2022 -414.00
Mar 31, 2022 201.00
Dec 31, 2021 196.00
Sep 30, 2021 -125.00
Jun 30, 2021 -75.00